作者: Amanda B. Cooper , Rebecca Slack , David Fogelman , Holly M. Holmes , Maria Petzel
DOI: 10.1245/S10434-014-4285-2
关键词: Internal medicine 、 Survival rate 、 Pancreatic cancer 、 Medicine 、 Clinical trial 、 Neoadjuvant therapy 、 Oncology 、 Pancreatectomy 、 Carcinoma 、 Surgical oncology 、 Combined Modality Therapy
摘要: Background Little is known about changes in body composition that may occur during neoadjuvant therapy for pancreatic cancer. This study was designed to characterize these …